drugset / Trial / NCT02834819

Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis

NCT02834819

Terminated 18 enrolled University of Colorado, Denver
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether nebulized 3% hypertonic saline is more effective than the current standard of care in the treatment of viral bronchiolitis in children.

Timeline

Start
2013-09
Primary completion
2015-09
Completion
2015-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 3 % Inhaled

Indications